Adjuvant Radiotherapy Versus Wait-and-see Strategy for Pathologic T3 or Margin-positive Prostate Cancer: A Meta-analysis

M. Parvez Shaikh, Fiori Alite, Meng-jia Wu, Abhishek A. Solanki, Matthew M. Harkenrider

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	American Journal of Clinical Oncology
DOIs	https://doi.org/10.1097/COC.0000000000000358
State	Published - Jan 2 2017

Disciplines

@article{0519b99ff7044282b525bb192bfc3654,

title = "Adjuvant Radiotherapy Versus Wait-and-see Strategy for Pathologic T3 or Margin-positive Prostate Cancer: A Meta-analysis",

author = "Shaikh, {M. Parvez} and Fiori Alite and Meng-jia Wu and Solanki, {Abhishek A.} and Harkenrider, {Matthew M.}",

year = "2017",

month = jan,

day = "2",

doi = "10.1097/COC.0000000000000358",

language = "American English",

journal = "American Journal of Clinical Oncology",

}

TY - JOUR

T1 - Adjuvant Radiotherapy Versus Wait-and-see Strategy for Pathologic T3 or Margin-positive Prostate Cancer: A Meta-analysis

AU - Shaikh, M. Parvez

AU - Alite, Fiori

AU - Wu, Meng-jia

AU - Solanki, Abhishek A.

AU - Harkenrider, Matthew M.

PY - 2017/1/2

Y1 - 2017/1/2

UR - http://Insights.ovid.com/crossref?an=00000421-900000000-98983

U2 - 10.1097/COC.0000000000000358

DO - 10.1097/COC.0000000000000358

M3 - Article

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

ER -